Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.62 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.62 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.62 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.62 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.62 |
| ▸ | ADH5 | P11766 | 1/20 | 0.60 |
| ▸ | MEN1 | O00255 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.57 |
| ▸ | RPA1 | P27694 | 1/20 | 0.50 |
| ▸ | ATM | Q13315 | 1/20 | 0.50 |
| ▸ | USP2 | O75604 | 1/20 | 0.48 |
| ▸ | HCAR2 | Q8TDS4 | 3/20 | 0.48 |
| ▸ | PBRM1 | Q86U86 | 1/20 | 0.46 |
| ▸ | IDO1 | P14902 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | LDHA | P00338 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9984638 | 0.78 | ADH5 (0.95) | ALDH1A1ADH5MEN1KMT2AL3MBTL1 | |
| SCHEMBL7196747 | 0.74 | ALDH1A1 (0.41) | ALDH1A1ALOX15CYP3A4HIF1AHSD17B10 | |
| SCHEMBL4983079 | 0.71 | HPGDS (0.75) | ALDH1A1ADH5MEN1KMT2AL3MBTL1 | |
| SCHEMBL2932335 | 0.71 | ADH5 (0.71) | ALDH1A1ADH5MEN1KMT2AL3MBTL1 | |
| SCHEMBL9984679 | 0.71 | ALDH1A1 (0.38) | ALDH1A1ALOX15CYP3A4HIF1AHSD17B10 | |
| SCHEMBL2645809 | 0.69 | ADH5 (0.75) | ALDH1A1ADH5RPA1ATMTP53 | |
| SCHEMBL10111979 | 0.69 | ATM (0.44) | ALDH1A1ALOX15CYP3A4HIF1AHSD17B10 | |
| SCHEMBL1777649 | 0.69 | ADH5 (0.75) | ALDH1A1HSD17B10ADH5RPA1ATM | |
| SCHEMBL14347139 | 0.69 | ADH5 (0.75) | ALDH1A1HSD17B10ADH5RPA1ATM | |
| SCHEMBL2645811 | 0.69 | ADH5 (0.75) | ALDH1A1ADH5MEN1KMT2ARPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9918964-B2 | Reducing platelet activation, aggregation and platelet-stimulated thrombosis or blood coagulation by reducing mitochondrial respiration | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2018-03-20 | — | — | US | claimed |
| CN-114072488-B | Etching composition | 富士胶片电子材料美国有限公司 | 2024-08-09 | — | — | CN | disclosed |
| CN-117946519-A | Curable resin composition, temporary fixing material, and method for producing electronic component | 积水化学工业株式会社 | 2024-04-30 | — | — | CN | disclosed |
| CN-115702212-B | Curable resin composition, temporary fixing material, and method for producing electronic component | 积水化学工业株式会社 | 2024-01-12 | — | — | CN | disclosed |
| US-20230219866-A1 | GAS GENERATING COMPOSITIONS AND METHODS OF USING | DEUTSCHE BANK TRUST COMPANY AMERICAS | 2023-07-13 | — | — | US | disclosed |
| CN-115917706-A | Temporary fixing material and method for manufacturing electronic component | 积水化学工业株式会社 | 2023-04-04 | — | — | CN | disclosed |
| CN-115702212-A | Curable resin composition, temporary fixing material, and method for producing electronic component | 积水化学工业株式会社 | 2023-02-14 | — | — | CN | disclosed |
| CN-114072488-A | Etching composition | 富士胶片电子材料美国有限公司 | 2022-02-18 | — | — | CN | disclosed |
| US-20190085208-A1 | POLISHING COMPOSITION, METHOD FOR PRODUCING SAME, POLISHING METHOD, AND METHOD FOR PRODUCING SUBSTRATE | FUJIMI INCORPORATED (JP) | 2019-03-21 | — | — | US | disclosed |
| US-9918964-B2 | Reducing platelet activation, aggregation and platelet-stimulated thrombosis or blood coagulation by reducing mitochondrial respiration | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2018-03-20 | — | — | US | disclosed |
| US-9918964-B2 | Reducing platelet activation, aggregation and platelet-stimulated thrombosis or blood coagulation by reducing mitochondrial respiration | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2018-03-20 | — | — | US | disclosed |
| US-9918964-B2 | Reducing platelet activation, aggregation and platelet-stimulated thrombosis or blood coagulation by reducing mitochondrial respiration | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2018-03-20 | — | — | US | disclosed |
| US-20110301180-A1 | Reducing Platelet Activation, Aggregation and Platelet-Stimulated Thrombosis or Blood Coagulation by Reducing Mitochondrial Respiration | STANFORD UNIVERSITY (US) | 2011-12-08 | — | — | US | disclosed |
| US-20110301180-A1 | Reducing Platelet Activation, Aggregation and Platelet-Stimulated Thrombosis or Blood Coagulation by Reducing Mitochondrial Respiration | STANFORD UNIVERSITY (US) | 2011-12-08 | — | — | US | disclosed |
| US-20110301180-A1 | Reducing Platelet Activation, Aggregation and Platelet-Stimulated Thrombosis or Blood Coagulation by Reducing Mitochondrial Respiration | STANFORD UNIVERSITY (US) | 2011-12-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110301180-A1 | Reducing Platelet Activation, Aggregation and Platelet-Stimulated Thrombosis or Blood Coagulation by Reducing Mitochondrial Respiration | PC, PFKP, UQCRC1 | ALDH1A1 1585/4885ALOX15 319/4885CYP3A4 338/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.